People with aging-associated farsightedness gained a new topical treatment option as the FDA expanded the approval of ...

Many of the panel members are new appointees with financial stakes in the peptide industry. In an email, Department of Health ...

Duplications in the alimentary canal can occur anywhere between the mouth and the anus, and are seen in about 1 in 4,500 ...

Forty percent of the U.S. science Nobel Prizes were won by immigrants. Omar Yaghi, PhD, a 2025 Nobel Prize winner for ...

In a recent viewpoint, Osterholm, executive director of the Vaccine Integrity Project, emphasized the need for predetermined ...

We have a responsibility to explain to patients how policy changes may transform their care ...

"Tech is not good or bad, but neither is it neutral." -- Mishal Khan, PhD, of the UC Berkeley Labor Center in California, on ...

(Traditional Medicare has increasingly come to resemble private insurance with premiums and coinsurance, and, unlike standard ...

When I led the military health system, I was asked to help a service member whose family had been transferred to a military ...

The FDA approved satralizumab (Enspryng), the first and only at-home subcutaneous treatment option for adults with thyroid eye disease (TED), developer Roche announced on Thursday.

Journalist Katie Couric recently shared her experience of sudden memory loss that persisted for several hours during a recent trip to Colorado. Doctors diagnosed the episode as transient global ...

Two decades ago, makeover shows dominated reality TV, but one show took it further than the rest. Now, in a new documentary, ...